The FDA was anticipating 3 vaccine manufacturers to apply for EUA for their COVID-19 vaccines.
The Food and Drug Administration (FDA) was anticipating 3 vaccine manufacturers to apply for emergency use authorization (EUA) for their respective COVID-19 vaccines.
In a report on Manila Bulletin, FDA Director-General Rolando Enrique “Eric” Domingo said during the Cabinet meeting on Wednesday night that his office already had meetings with the representatives of Moderna, Janssen Pharmaceuticals, and Serum Institute of India.
Domingo also said that they did follow ups on vaccine manufacturers regularly.
“Nakausap na po namin several times iyan at alam na (nila) ang requirements and encouraged them to start applying already pero until now hindi pa rin sila naga-apply. So, fina-follow namin sila regularly and sinasabi na nagpre-prepare palang sila ng kanilang application,” Domingo said.
READ ALSO: Second Batch Of China-Donated Sinovac COVID-19 Vaccine Doses Arrive In The Philippines
Currently, Domingo said that the Food and Drug Administration was reviewing the EUA application of India’s Bharat Biotech.
So far, the Food and Drug Administration (FDA) had granted an emergency use authorization (EUA) to the Pfizer-BioNTech COVID-19 vaccine, AstraZeneca-Oxford COVID-19 vaccine, Sinovac COVID-19 vaccine, and Sputnik V COVID-19 vaccine.
In a related development, Domingo reiterated that China’s Sinovac COVID-19 vaccine was still currently intended for healthy individuals aged 18 to 59 years old.
According to Domingo, the Sinovac COVID-19 vaccine was approved for use in 15 countries, but four of these countries — including the Philippines — were not recommending it for the elderly population as of this writing.
What can you say about this? Let us know your thoughts in the comments below.
For more news and updates, you may feel free to visit this site more often. You may also visit Newspapers.ph via our official Facebook page and YouTube channel.
